← All organizations

Mapi Pharma Ltd.

For profitWebsite ↗

Also known as: Coordinating PI | MAPI Group | Mapi Pharma Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 1, 2025

Acquired by ICON on Jul 27, 2017

Timeline

2000s

Jan 1, 2008
Mapi Pharma Ltd.— Founded

2010s

Jul 27, 2017
ICON— Acquired By

Drugs by trial phase (2 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

glatiramer acetate

Phase 2 (1 own, 0 via acquisition)

cariprazine

Indications

Studied for

Recent trials (6)

NCT07185815Lead sponsorPhase 1/Phase 2Aug 1, 2025
NCT04121221Lead sponsorPhase 3Sep 19, 2019
NCT04121221Study directorPhase 3Sep 19, 2019
NCT03362294Overall official - principal investigatorPhase 2Dec 11, 2017
NCT03362294Lead sponsorPhase 2Dec 11, 2017
NCT02212886Lead sponsorPhase 1/Phase 2Oct 1, 2014

Details

Founded: Ness Ziona, IL Jan 1, 2008
Last known activity: Aug 1, 2025